Healthcare & Life Sciences
i20 Therapeutics
United Statesi2obio.com
i20 Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 2 tracked investors.
Activeseed
seed
Stage
2019
Founded
2
Investors
About i20 Therapeutics
i20 Therapeutics is a company founded in 2019 headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
oral delivery platform for previously injected drugs
Explore i20 Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.